by [email protected] | Jul 20, 2021 | Cardiovascular, Publication
Abstract Background: This study primarily evaluates the risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among patients with VTE and active cancer prescribed apixaban, low-molecular-weight heparin (LMWH), or warfarin, with claims data....
by [email protected] | Jul 20, 2021 | Cancer (solid tumor), Publication
Abstract Introduction: Substantial unmet needs exist among patients with metastatic renal cell carcinoma (mRCC). This retrospective study evaluated treatment patterns as well as clinical and economic outcomes associated with first-line monotherapy among...
by [email protected] | Dec 21, 2020 | Cardiovascular, Publication
Abstract Authors: Jennifer D Guo, Patrick Hlavacek, Lisa Rosenblatt, Allison Keshishian, Cristina Russ, Jack Mardekian, Mauricio Ferri, Tayla Poretta, Huseyin Yuce, Robert McBane Background: The AMPLIFY trial found significantly lower major bleeding (MB)...
by [email protected] | Nov 2, 2020 | Gastrointestinal, immunology, Publication
Abstract Authors: David T Rubin, Jenny Griffith, Qisu Zhang, Zsolt Hepp, Allison Keshishian Background: Although there is evidence that anti-tumor necrosis factor (TNF) utilization earlier in the inflammatory bowel disease (IBD) course and before the...
by [email protected] | Nov 2, 2020 | Infectious Disease, Publication
Abstract Authors: Bolge SC, Kariburyo F, Yuce H, Fleischhackl R Introduction: The purpose of this study was to identify predictors of initial hospitalization and describe the outcomes of high-risk patients hospitalized with influenza. Methods: Data were...
by [email protected] | Oct 16, 2020 | Gastrointestinal, immunology, Publication
Abstract Authors: Chen G, Lissoos T, Dieyi C, Null KD Background Clinical indices to characterize the severity of inflammatory bowel disease (IBD) are widely used in clinical trials and real-world practice. However, there are few validated instruments for assessing...
